⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CLNN News
Clene Inc. Common Stock
Presenting on Emerging Growth Conference 95 Day 2 on August 20; Register to live stream
globenewswire.com
SBC
AEMD
CLNN
OESX
IMRN
ASPI
ZENA
Presenting on Emerging Growth Conference 95 Day 1 on August 19; Register to live stream
globenewswire.com
AEMD
ASPI
CLNN
IMRN
OESX
SBC
ZENA
AIB
Clene to Present at the Emerging Growth Conference
globenewswire.com
CLNN
Form 8-K
sec.gov
CLNN
Clene Reports Second Quarter 2026 Financial Results and Recent Operating Highlights
globenewswire.com
CLNN
Form 8-K
sec.gov
CLNN
Clene Announces Biomarker Analyses To Be Included in NDA Submission Supporting ALS Accelerated Approval
globenewswire.com
CLNN
Clene to Present at The Canaccord 46th Annual Growth Conference
globenewswire.com
CLNN
Novel Patented Myelin Drug-Discovery Strategy Targets Massive Unmet Need in Multiple Sclerosis
globenewswire.com
QNTM
SNY
BIIB
CLNN
Treg Cell-Based Therapies Clinical Trial Pipeline Appears Robust With 29+ Key Pharma Companies Actively Working in the Domain | DelveInsight
globenewswire.com
RAPT
SANG
INCY
ABBV
ARCT
AMGN
CHKP
PFE
LLY
SCLX
SNY
UCB
BIIB
NVS
VTRS
BMY
ABSI
ALEC
GSK
IONS
CLNN
ANNX
MED
GAM
VRTX
EXC
BLRX